(Q39586490)

English

Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2.

scientific article published on 18 July 2016

Statements

Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2. (English)
0 references
0 references
Filippo De Marinis
Harry J M Groen
Heather Wakelee
Giorgio Scagliotti
Fabrice Branle
Chetachi Emeremni
Massimiliano Quadrigli

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit